OptimizeRx
OPRX
38 hedge funds and large institutions have $45.9M invested in OptimizeRx in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
31% more funds holding
Funds holding: 29 → 38 (+9)
11.82% more ownership
Funds ownership: 23.04% → 34.86% (+12%)
5% less capital invested
Capital invested by funds: $48.3M → $45.9M (-$2.36M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$5.55M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.79M |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$2.22M |
| 4 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$1.96M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IP
Intellectus Partners
San Francisco,
California
|
-$1.17M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$482K |
| 3 |
Millennium Management
New York
|
-$479K |
| 4 |
FM
Family Management
New York
|
-$240K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$240K |
OPRX Hedge Fund Activity: Q4 2018 in Review
38 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2018, worth a combined $45.9M — down 4.9% from $48.3M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new OPRX positions and 4 closed out — a net gain of 9 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Park West Asset Management, adding an estimated $5.55M. The largest seller was Intellectus Partners, exiting entirely with an estimated $1.17M sold.
- 38 institutional investors held OptimizeRx (OPRX) as of Q4 2018, up from 29 in Q3 2018.
- Funds reported $45.9M of OptimizeRx stock for Q4 2018, down 4.9% quarter-over-quarter.
- 13 funds opened new OptimizeRx positions in Q4 2018 and 4 closed out, a net change of +9 holders.
- The largest OptimizeRx buyer in Q4 2018 was Park West Asset Management, an estimated $5.55M added.
- The largest OptimizeRx seller in Q4 2018 was Intellectus Partners, an estimated $1.17M sold.
Based on aggregated 13F filings for Q4 2018.